These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 30499744)

  • 21. Fighting high molecular weight in bioactive molecules with sub-pharmacophore-based virtual screening.
    von Korff M; Freyss J; Sander T; Boss C; Ciana CL
    J Chem Inf Model; 2012 Feb; 52(2):380-90. PubMed ID: 22251316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel 2D fingerprints for ligand-based virtual screening.
    Ewing T; Baber JC; Feher M
    J Chem Inf Model; 2006; 46(6):2423-31. PubMed ID: 17125184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereoselective virtual screening of the ZINC database using atom pair 3D-fingerprints.
    Awale M; Jin X; Reymond JL
    J Cheminform; 2015; 7():3. PubMed ID: 25750664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FaissMolLib: An efficient and easy deployable tool for ligand-based virtual screening.
    Liu H; Chen P; Hu B; Wang S; Wang H; Luan J; Wang J; Lin B; Cheng M
    Comput Biol Chem; 2024 Jun; 110():108057. PubMed ID: 38581840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LBVS: an online platform for ligand-based virtual screening using publicly accessible databases.
    Zheng M; Liu Z; Yan X; Ding Q; Gu Q; Xu J
    Mol Divers; 2014 Nov; 18(4):829-40. PubMed ID: 25182364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. gWEGA: GPU-accelerated WEGA for molecular superposition and shape comparison.
    Yan X; Li J; Gu Q; Xu J
    J Comput Chem; 2014 Jun; 35(15):1122-30. PubMed ID: 24729358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RealVS: Toward Enhancing the Precision of Top Hits in Ligand-Based Virtual Screening of Drug Leads from Large Compound Databases.
    Yin Y; Hu H; Yang Z; Xu H; Wu J
    J Chem Inf Model; 2021 Oct; 61(10):4924-4939. PubMed ID: 34619030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring chemical space for drug discovery using the chemical universe database.
    Reymond JL; Awale M
    ACS Chem Neurosci; 2012 Sep; 3(9):649-57. PubMed ID: 23019491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "Bayes affinity fingerprints" improve retrieval rates in virtual screening and define orthogonal bioactivity space: when are multitarget drugs a feasible concept?
    Bender A; Jenkins JL; Glick M; Deng Z; Nettles JH; Davies JW
    J Chem Inf Model; 2006; 46(6):2445-56. PubMed ID: 17125186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Virtual screening in drug discovery -- a computational perspective.
    Reddy AS; Pati SP; Kumar PP; Pradeep HN; Sastry GN
    Curr Protein Pept Sci; 2007 Aug; 8(4):329-51. PubMed ID: 17696867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NALDB: nucleic acid ligand database for small molecules targeting nucleic acid.
    Kumar Mishra S; Kumar A
    Database (Oxford); 2016; 2016():. PubMed ID: 26896846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of Open Source Tools and Resources in Virtual Screening for Drug Discovery.
    Karthikeyan M; Vyas R
    Comb Chem High Throughput Screen; 2015; 18(6):528-43. PubMed ID: 26138575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methods for generating and applying pharmacophore models as virtual screening filters and for bioactivity profiling.
    Vuorinen A; Schuster D
    Methods; 2015 Jan; 71():113-34. PubMed ID: 25461773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Portals and Web-Based Resources for Virtual Screening.
    Krüger J; Thiel P; Merelli I; Grunzke R; Gesing S
    Curr Drug Targets; 2016; 17(14):1649-1660. PubMed ID: 26844570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular Similarity for Drug Discovery, Target Prediction and Chemical Space Visualization.
    Reymond JL
    Chimia (Aarau); 2022 Dec; 76(12):1045-1051. PubMed ID: 38069801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacophore-based discovery of ligands for drug transporters.
    Chang C; Ekins S; Bahadduri P; Swaan PW
    Adv Drug Deliv Rev; 2006 Nov; 58(12-13):1431-50. PubMed ID: 17097188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The discovery of novel β-secretase inhibitors: pharmacophore modeling, virtual screening, and docking studies.
    Niu Y; Ma C; Jin H; Xu F; Gao H; Liu P; Li Y; Wang C; Yang G; Xu P
    Chem Biol Drug Des; 2012 Jun; 79(6):972-80. PubMed ID: 22381116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel technologies for virtual screening.
    Lengauer T; Lemmen C; Rarey M; Zimmermann M
    Drug Discov Today; 2004 Jan; 9(1):27-34. PubMed ID: 14761803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ProBiS tools (algorithm, database, and web servers) for predicting and modeling of biologically interesting proteins.
    Konc J; Janežič D
    Prog Biophys Mol Biol; 2017 Sep; 128():24-32. PubMed ID: 28212856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Virtual screening data fusion using both structure- and ligand-based methods.
    Svensson F; Karlén A; Sköld C
    J Chem Inf Model; 2012 Jan; 52(1):225-32. PubMed ID: 22148635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.